ICS 11.120.01

Pharmaceutics in general

Standards in This Category

SM EN 1041+A1:2015

Information Provided by the Medical Device Manufacturer

2015-02-03
This document establishes a framework for the provision of essential information by equipment manufacturers to end-users, ensuring clarity and safety in product usage. It specifies the requirements
SM SR EN 980:2010

Simboluri utilizate pentru etichetarea dispozitivelor medicale

2010-12-20
This specification establishes a standardized set of graphical symbols designated for use on the labels of medical devices. These visual indicators serve to convey critical information regarding
SMV EN 980:2009

Simboluri utilizate pentru etichetarea dispozitivelor medicale

2009-04-23
This document outlines a standardized set of graphical symbols specifically designed for use on medical device labeling. It establishes a consistent visual language to ensure that critical
MSZ EN 14375:2004
MSZT

Child-resistant non-reclosable packaging for pharmaceutical products. Requirements and testing

2004-06-01 Replaced
This standard establishes comprehensive requirements and testing methodologies specifically designed for child-resistant packaging used in pharmaceutical products. It outlines precise criteria to
T/CNPPA 3033-2026
TUANTI

Technical requirement for ready to sterilize rubber closures

2026-04-07
This document outlines the specialized technical requirements specifically designed for rubber seals intended for sterilization processes. It establishes precise criteria regarding material
T/CNPPA 3013-2026
TUANTI

Guidance for good manufacturing practice for pharmaceutical rubber closures

2026-04-07
This technical specification establishes a comprehensive framework for managing production quality within the pharmaceutical rubber sealing component manufacturing sector. It provides detailed
T/CNPPA 3034-2026
TUANTI

Guidance of the performance testing for the transport packages of pharmaceutical products

2026-04-07
This document establishes a comprehensive framework for evaluating the performance of pharmaceutical packaging during transportation. It outlines specific test methodologies designed to assess how
T/CNPPA 3015-2026
TUANTI

On-site audit guide for suppliers of pharmaceutical rubber seals

2026-02-02
This document establishes a systematic framework for conducting on-site audits of suppliers providing rubber sealing components intended for pharmaceutical applications. The guidelines define
IRAM 9800-6:2023
IRAM

Good pharmacy practice. Medical devices dispensing management in health establishments.

2023-12-28
IRAM 9801:2022
IRAM

Good pharmacy practice. Vocabulary

2022-11-04
IRAM 37628:2021
IRAM

Medicinal plants. Peperina mint, Minthostachys verticillata (Griseb.) Epling - Lamiaceae and its comparison with Peperina chilena or False peperina mint, Clinopodium nepeta (L.) Kuntze – Lamiaceae.

2021-07-16
IRAM 37631:2021
IRAM

Medicinal plants. Cáñamo, Cannabis sativa L. (Cannabaceae). Requirements.

2021-07-16
IRAM 37638:2022
IRAM

Medicinal plants. Ambay, amb-ahú, amba’y, palo de lija, Cecropia pachystachya Trécul (Urticaceae). Requirements

2022-11-28
IRAM 37637:2022
IRAM

Medicinal plants. Ginko, Ginko biloba L. (Ginkgoaceae). Requirements

2022-11-28
MSZ EN 12442-2:2001
MSZT

Animal tissues and their derivatives utilized in the manufacture of medical devices. Part 2: Controls on sourcing, collection and handling

2001-10-01
This document establishes specific regulatory requirements concerning the utilization of animal tissues and their derivatives within the context of medical device manufacturing. It focuses
MSZ EN 12442-1:2001
MSZT

Animal tissues and their derivatives utilized in the manufacture of medical devices. Part 1: Analysis and management of risk

2001-10-01
This document establishes a comprehensive framework for managing risks associated with the use of animal-derived tissues and their derivatives in the manufacturing of medical devices. It focuses
MSZ EN 12442-3:2001
MSZT

Animal tissues and their derivatives utilized in the manufacture of medical devices. Part 3: Validation of the elimination and/or inactivation of viruses and transmissible agents

2001-10-01
This standard establishes a framework for validating the processes involved in removing and/or inactivating viruses and transmissible agents within animal-derived materials and their derivatives used
TZS 2797:2022
TBS

Sterilized sodium chloride intravenous infusion

2022
TZS 2798:2022
TBS

Sterilized sodium chloride and dextrose intravenous infusion

2022
TZS 2796:2022
TBS

Sterilized compound sodium lactate intravenous infusion (Ringers-lactate solution for injection)

2022